Davis R M Inc. reduced its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 0.9% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 479,813 shares of the company’s stock after selling 4,509 shares during the period. Davis R M Inc.’s holdings in Henry Schein were worth $33,529,000 at the end of the most recent reporting period.
Several other hedge funds have also bought and sold shares of HSIC. YorkBridge Wealth Partners LLC grew its holdings in shares of Henry Schein by 5.2% in the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock valued at $104,000 after purchasing an additional 28 shares in the last quarter. Sun Life Financial INC grew its holdings in shares of Henry Schein by 8,185.7% in the second quarter. Sun Life Financial INC now owns 580 shares of the company’s stock valued at $106,000 after purchasing an additional 573 shares in the last quarter. FTB Advisors Inc. grew its holdings in shares of Henry Schein by 100.0% in the third quarter. FTB Advisors Inc. now owns 1,484 shares of the company’s stock valued at $120,000 after purchasing an additional 742 shares in the last quarter. Trust Co. of Vermont grew its holdings in shares of Henry Schein by 56.7% in the third quarter. Trust Co. of Vermont now owns 1,702 shares of the company’s stock valued at $140,000 after purchasing an additional 616 shares in the last quarter. Finally, Lee Financial Co grew its holdings in shares of Henry Schein by 100.0% in the third quarter. Lee Financial Co now owns 1,756 shares of the company’s stock valued at $144,000 after purchasing an additional 878 shares in the last quarter. 91.70% of the stock is owned by hedge funds and other institutional investors.
In other news, Director Barry J. Alperin sold 5,796 shares of Henry Schein stock in a transaction on Friday, December 1st. The stock was sold at an average price of $70.76, for a total transaction of $410,124.96. Following the completion of the sale, the director now directly owns 48,172 shares in the company, valued at $3,408,650.72. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.19% of the stock is currently owned by company insiders.
Shares of Henry Schein, Inc. (NASDAQ HSIC) traded up $1.54 on Tuesday, reaching $74.84. The company had a trading volume of 1,045,500 shares, compared to its average volume of 1,296,067. Henry Schein, Inc. has a 12 month low of $65.28 and a 12 month high of $93.50. The company has a market capitalization of $11,746.47, a P/E ratio of 21.57, a PEG ratio of 1.91 and a beta of 1.00. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.86 and a current ratio of 1.55.
Henry Schein (NASDAQ:HSIC) last released its earnings results on Monday, November 6th. The company reported $0.87 earnings per share for the quarter, missing the consensus estimate of $0.90 by ($0.03). Henry Schein had a return on equity of 19.71% and a net margin of 4.52%. The business had revenue of $3.16 billion for the quarter, compared to the consensus estimate of $3.05 billion. During the same quarter last year, the business posted $0.84 earnings per share. The firm’s revenue for the quarter was up 10.3% compared to the same quarter last year. sell-side analysts anticipate that Henry Schein, Inc. will post 3.6 EPS for the current year.
Henry Schein announced that its board has authorized a stock repurchase program on Monday, September 18th that allows the company to buyback $400.00 million in shares. This buyback authorization allows the company to purchase up to 6.3% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s management believes its shares are undervalued.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.